Get started
Author

Anamaria Crisan

Observed names: A Crisan, A. Crisan
Institution: Genome Canada
OpenAlex ID: A5083500842
Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
2013 · Nicholas Erho, Anamaria Crisan, et al. · PLoS ONE · 644
PDF
Validation of a Genomic Classifier that Predicts Metastasis Following Radical Prostatectomy in an At Risk Patient Population
2013 · R. Jeffrey Karnes, Eric J. Bergstralh, et al. · The Journal of Urology · 325
Combined Value of Validated Clinical and Genomic Risk Stratification Tools for Predicting Prostate Cancer Mortality in a High-risk Prostatectomy Cohort
2014 · Matthew R. Cooperberg, Elai Davicioni, et al. · European Urology · 194
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
2013 · A E Ross, F Y Feng, et al. · Prostate Cancer and Prostatic Diseases · 128
Genomic “Dark Matter” in Prostate Cancer: Exploring the Clinical Utility of ncRNA as Biomarkers
2012 · Ismael A. Vergara, Nicholas Erho, et al. · Frontiers in Genetics · 23
PDF
Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence
2014 · Mohammed Alshalalfa, Anamaria Crisan, et al. · British Journal of Urology · 21
PDF
Whole-Transcriptome Profiling of Thyroid Nodules Identifies Expression-Based Signatures for Accurate Thyroid Cancer Diagnosis
2013 · Sam M. Wiseman, Zaid Haddad, et al. · The Journal of Clinical Endocrinology & Metabolism · 16
Validation of a genomic-clinical classifier model for predicting clinical recurrence of patients with localized prostate cancer in a high-risk population.
2012 · Robert B. Jenkins, Eric J Bergstralh, et al. · Journal of Clinical Oncology · 3
2130 Validation of a Genomic Classifier That Predicts Metastatic Disease Progression in Men With High Risk Pathological Features Post-prostatectomy
2013 · R. Jeffrey Karnes, Mercedeh Ghadessi, et al. · The Journal of Urology · 2
Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy.
2013 · Mercedeh Ghadessi, Eric J. Bergstralh, et al. · Journal of Clinical Oncology · 2
Clinical and genomic analysis of metastatic disease progression in a background of biochemical recurrence.
2012 · Anamaria Crisan, Mercedeh Ghadessi, et al. · Journal of Clinical Oncology · 2
Development and validation of a digital Gleason score biomarker signature for risk stratification of patients with prostate cancer.
2012 · Nicholas Erho, Ismael A. Vergara, et al. · Journal of Clinical Oncology · 2
Validation of a Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post-Radical Prostatectomy
2013 · F.Y. Feng, M. Ghadessi, et al. · International Journal of Radiation Oncology*Biology*Physics · 1
PDF
Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy.
2013 · Ashley E. Ross, Mercedeh Ghadessi, et al. · Journal of Clinical Oncology · 1
2229 Comparison of Clinical and Genomic Models for Prediction of Rapid Metastatic Disease After Radical Prostatectomy
2013 · Ashley Ross, Mercedeh Ghadessi, et al. · The Journal of Urology · 1
2239 Clinical and Genomic Analysis of Metastatic Disease Progression in a Background of Biochemical Recurrence
2013 · Anamaria Crisan, Ismael Vergara, et al. · The Journal of Urology · 1
6089 FOLFOX-4 versus FOLFIRI in the treatment of metastatic colorectal cancer–aprospective randomised study
2009 · F. Badulescu, A. Badulescu, et al. · European Journal of Cancer Supplements · 1
Reconsidering Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Using an Individualized Decision Analysis With Genomic Classifier Scores
2014 · D. Trifiletti, J. Mason, et al. · International Journal of Radiation Oncology*Biology*Physics
PDF
Development of a genomic-clinical classifier for predicting progression after radical cystectomy in patients with muscle invasive bladder cancer.
2013 · Anirban Pradip Mitra, Nicholas Erho, et al. · Journal of Clinical Oncology
The role of advanced genetic testing in the management of prostate cancer post radical prostatectomy.
2013 · Edward M. Schaeffer, Ismael A. Vergara, et al. · Journal of Clinical Oncology
2230 Evaluation of a Genomic Classifier for Improved Risk Stratification in Prostate Cancer Patients With Specific Adverse Pathologies After Surgery
2013 · Doug Dolginow, Anamaria Crisan, et al. · The Journal of Urology
2243 Combined Value of Genomic Biomarkers and Capra-s in Predicting Prostate Cancer Death in a High-risk Surgical Cohort
2013 · Matthew Cooperberg, Anamaria Crisan, et al. · The Journal of Urology
2240 Performance of a Genomic Classifier That Predicts Metastatic Disease Progression in Men With Biochemical Recurrence Post Radical Prostatectomy
2013 · Ashley E. Ross, Mercedeh Ghadessi, et al. · The Journal of Urology
A genomic classifier independently prognostic of prostate cancer death in a high-risk surgical cohort.
2013 · Matthew R. Cooperberg, Anamaria Crisan, et al. · Journal of Clinical Oncology
Validation of a genomic classifier that predicts metastatic disease progression in men with biochemical recurrence post radical prostatectomy.
2013 · Ashley E. Ross, Mercedeh Ghadessi, et al. · Journal of Clinical Oncology
Works count: 32
Citation count: 1,367
H-index: 7
I10-index: 7
Year
Topic
Type